Preop MRI Recommended for All New Breast Cancer Patients
Preoperative MRIs should be done on all newly diagnosed breast cancer patients, regardless of breast density.
Preoperative MRIs should be done on all newly diagnosed breast cancer patients, regardless of breast density, say researchers from Yale University School of Medicine in New Haven. The results of their study were presented at the American Roentgen Ray Society Annual Meeting in Vancouver, Canada.
Preop MRIs are ordered more often for young women or those who have dense breasts, said Reena Vashi, MD, one of the study authors. However, researchers studied 127 patients to determine if 3T MRI could be of use preoperatively in detecting additional malignancies - regardless of age or breast tissue density.
The researchers found that preop MRIs detected additional malignancies in 26 percent of patients whose breasts were not considered dense and in 25 percent of patients with dense breast tissue. There were no differences between the groups regarding the sizes or distribution of the lesions.
In addition, there were several patients who had unsuspected additional cancers in the opposite breast or in a separate quadrant from the known cancer in the affected breast, the researchers discovered.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
